Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1060 (LINC01060) is a human long non-coding RNA (lncRNA) gene located on chromosome 4 that does not encode a protein[1][3][6]. It represents a subclass of lncRNAs known as long intergenic non-coding RNAs (lincRNAs), which are transcribed from genomic regions not overlapping with protein-coding genes, and are generally longer than 200 nucleotides[7]. While the functions of many lincRNAs remain unclear, LINC01060 has been shown to suppress pancreatic cancer progression by regulating the expression of vinculin, suggesting a potential role in cancer biology, especially as a tumor suppressor[6]. Like other lincRNAs, it may participate in regulating gene transcription, chromatin remodeling, and epigenetic modification, though detailed mechanisms for this specific lncRNA are still under investigation[6][7]. There are currently no known drugs that specifically target LINC01060, and it is not currently classified as a therapeutic target like receptors or enzymes[6][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1060 (LINC01060).